Srivastava, R. M., Trivedi, S., Concha-Benavente, F., Hyun-bae, J., Wang, L., Seethala, R. R., . . . Ferris, R. L. (2015). STAT1-Induced HLA class I Upregulation Enhances Immunogenicity and Clinical Response to anti-EGFR mAb Cetuximab Therapy in HNC Patients. Cancer Immunol Res.
Citação norma ChicagoSrivastava, Raghvendra M., Sumita Trivedi, Fernando Concha-Benavente, Jie Hyun-bae, Lin Wang, Raja R. Seethala, Barton F. Branstetter, Soldano Ferrone, and Robert L. Ferris. "STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR MAb Cetuximab Therapy in HNC Patients." Cancer Immunol Res 2015.
MLA citiranjeSrivastava, Raghvendra M., et al. "STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR MAb Cetuximab Therapy in HNC Patients." Cancer Immunol Res 2015.